Bisoprolol fumarate, a vital medication for managing high blood pressure and heart failure, has become a topic of ethical debate due to fluctuations in its active pharmaceutical ingredient (API) pricing. While ensuring a healthy profit margin is necessary for manufacturers to remain sustainable and invest in research, excessive pricing can limit patient access to this life-saving medication....
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian